10.3389/fnins.2021.673600 Summary Keywords iron chelation, intranasal delivery, neurodegenerative diseases, blood-brain barrier, brain delivery Citation Cheng R and Kim J (2025) Intranasal delivery of iron chelators and management of central nervous system disease
*Correspondence: Ahmad Hamad Alhowail, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
As an important regulator in cancer metabolism, dysregulated GGCT expression has been confirmed to be closely associated with the progression of multiple malignancies [3,4,5,6,7,8,9,10]
Additional research is needed to examine whether vitamin E supplementation has utility in the management of patients with mild-to-moderate cognitive impairments